{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:22:15Z","timestamp":1781911335777,"version":"3.54.5"},"publisher-location":"Cham","reference-count":38,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319557793","type":"print"},{"value":"9783319557809","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-55780-9_9","type":"book-chapter","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T12:13:52Z","timestamp":1501244032000},"page":"101-109","source":"Crossref","is-referenced-by-count":43,"title":["Liver Cancer in Tyrosinemia Type 1"],"prefix":"10.1007","author":[{"given":"Willem G.","family":"van Ginkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Pennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francjan J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,29]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","unstructured":"Arnon R, Annunziato R, Miloh T, Wasserstein M, Sogawa H, Wilson M,\u2026( Kerkar N (2011) Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database. Pediatr Transplant 15(4): 400\u2013405. doi:10.1111\/j.1399\u20133046.2011.01497.x [doi]","DOI":"10.1111\/j.1399-3046.2011.01497.x"},{"issue":"2","key":"9_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00261-011-9794-x [doi]","volume":"37","author":"C Ayuso","year":"2012","unstructured":"Ayuso C, Rimola J, Garcia-Criado A (2012) Imaging of HCC. Abdom Imaging 37(2):215\u2013230. doi:10.1007\/s00261-011-9794-x [doi]","journal-title":"Abdom Imaging"},{"issue":"1","key":"9_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.mpg.0000228112.29359.f8","volume":"43","author":"U Baumann","year":"2006","unstructured":"Baumann U, Duhme V, Auth MK, McKiernan PJ, Holme E (2006) Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma. J Pediatr Gastroenterol Nutr 43(1):77\u201382. doi: 10.1097\/01.mpg.0000228112.29359.f8","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9_CR4","doi-asserted-by":"publisher","unstructured":"Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C,\u2026 Reeves H (2008) AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 8: 200-2407-8-200. doi:10.1186\/1471-2407-8-200; 10.1186\/1471-2407-8-200","DOI":"10.1186\/1471-2407-8-200"},{"issue":"9","key":"9_CR5","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1074\/jbc.M506804200","volume":"281","author":"A Bergeron","year":"2006","unstructured":"Bergeron A, Jorquera R, Orejuela D, Tanguay RM (2006) Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I. J Biol Chem 281(9):5329\u20135334","journal-title":"J Biol Chem"},{"issue":"6","key":"9_CR6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0168-8278(03)00349-0","volume":"39","author":"L Bolondi","year":"2003","unstructured":"Bolondi L (2003) Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 39(6):1076\u20131084","journal-title":"J Hepatol"},{"key":"9_CR7","doi-asserted-by":"publisher","unstructured":"Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R,\u2026 Barcelona Clinic Liver Cancer Group (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology (Baltimore, Md), 38(4), 1034\u20131042. 10.1053\/jhep.2003.50409","DOI":"10.1053\/jhep.2003.50409"},{"issue":"2","key":"9_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1148\/rg.312105201","volume":"31","author":"EM Chung","year":"2011","unstructured":"Chung EM, Lattin GE Jr, Cube R, Lewis RB, Marichal-Hernandez C, Shawhan R, Conran RM (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. part 2. malignant tumors. Radiographics: A Rev Publ Radiol Soc N Am Inc 31(2):483\u2013507. doi: 10.1148\/rg.312105201","journal-title":"Radiographics: A Rev Publ Radiol Soc N Am Inc"},{"key":"9_CR9","doi-asserted-by":"publisher","unstructured":"de Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L,\u2026, Spiekerkotter U (2013) Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 8: 8\u20131172\u20138-8. doi: 10.1186\/1750-1172-8-8","DOI":"10.1186\/1750-1172-8-8"},{"issue":"2","key":"9_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0046-8177(89)90179-2","volume":"20","author":"LP Dehner","year":"1989","unstructured":"Dehner LP, Snover DC, Sharp HL, Ascher N, Nakhleh R, Day DL (1989) Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver. Hum Pathol 20(2):149\u2013158","journal-title":"Hum Pathol"},{"issue":"12","key":"9_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/BF03178035","volume":"26","author":"J Dubois","year":"1996","unstructured":"Dubois J, Garel L, Patriquin H, Paradis K, Forget S, Filiatrault D et al (1996) Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients. Pediatr Radiol 26(12):845\u2013851","journal-title":"Pediatr Radiol"},{"issue":"12","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683 [doi]","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118\u20131127. doi:10.1056\/NEJMra1001683 [doi]","journal-title":"N Engl J Med"},{"issue":"6","key":"9_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264\u20131273.e1. doi: 10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"issue":"9822","key":"9_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet (London, England) 379(9822):1245\u20131255. doi: 10.1016\/S0140-6736(11)61347-0","journal-title":"Lancet (London, England)"},{"key":"9_CR15","doi-asserted-by":"publisher","unstructured":"Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L,\u2026 Antonaci S (2007) Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta; Int J Clin Chem, 383(1\u20132): 147\u2013152. 10.1016\/j.cca.2007.05.014","DOI":"10.1016\/j.cca.2007.05.014"},{"issue":"11","key":"9_CR16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4254\/wjh.v7.i11.1509","volume":"7","author":"C Hackl","year":"2015","unstructured":"Hackl C, Schlitt HJ, Melter M, Knoppke B, Loss M (2015) Current developments in pediatric liver transplantation. World J Hepatol 7(11):1509\u20131520. doi: 10.4254\/wjh.v7.i11.1509","journal-title":"World J Hepatol"},{"issue":"8","key":"9_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/archdischild-2015-308265","volume":"100","author":"N Hadzic","year":"2015","unstructured":"Hadzic N, Vara R (2015) Neonatal screening for hereditary tyrosinaemia: are we there yet? Arch Dis Child 100(8):720\u2013721. doi: 10.1136\/archdischild-2015-308265","journal-title":"Arch Dis Child"},{"issue":"7","key":"9_CR18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s003300050845","volume":"9","author":"TK Helmberger","year":"1999","unstructured":"Helmberger TK, Ros PR, Mergo PJ, Tomczak R, Reiser MF (1999) Pediatric liver neoplasms: a radiologic-pathologic correlation. Eur Radiol 9(7):1339\u20131347. 90091339.330 [pii]","journal-title":"Eur Radiol"},{"issue":"5","key":"9_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1005410820201","volume":"21","author":"E Holme","year":"1998","unstructured":"Holme E, Lindstedt S (1998) Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 21(5):507\u2013517","journal-title":"J Inherit Metab Dis"},{"issue":"21","key":"9_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1056\/NEJM198305263082105","volume":"308","author":"MK Hostetter","year":"1983","unstructured":"Hostetter MK, Levy HL, Winter HS, Knight GJ, Haddow JE (1983) Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med 308(21):1265\u20131267. doi: 10.1056\/NEJM198305263082105","journal-title":"N Engl J Med"},{"issue":"17","key":"9_CR21","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/10.17.1741","volume":"10","author":"R Jorquera","year":"2001","unstructured":"Jorquera R, Tanguay RM (2001) Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum Mol Genet 10(17):1741\u20131752","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ymgme.2006.07.009","volume":"89","author":"CJ Koelink","year":"2006","unstructured":"Koelink CJ, van Hasselt P, van der Ploeg A, van den Heuvel-Eibrink MM, Wijburg FA, Bijleveld CM, van Spronsen FJ (2006) Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer? Mol Genet Metab 89(4):310\u2013315. doi: 10.1016\/j.ymgme.2006.07.009","journal-title":"Mol Genet Metab"},{"key":"9_CR23","doi-asserted-by":"publisher","unstructured":"Larochelle J, Alvarez F, Bussieres JF, Chevalier I, Dallaire L, Dubois J,\u2026 Mitchell GA (2012) Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in quebec. Mol Genet Metab 107(1\u20132):49\u201354. doi: 10.1016\/j.ymgme.2012.05.022 ; 10.1016\/j.ymgme.2012.05.022","DOI":"10.1016\/j.ymgme.2012.05.022"},{"issue":"8823","key":"9_CR24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","volume":"340","author":"S Lindstedt","year":"1992","unstructured":"Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340(8823):813\u2013817. doi:0140-6736(92)92685-9 [pii]","journal-title":"Lancet"},{"issue":"1","key":"9_CR25","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1542\/peds.2009-1639; 10.1542\/peds.2009-1639","volume":"126","author":"V Nobili","year":"2010","unstructured":"Nobili V, Jenkner A, Francalanci P, Castellano A, Holme E, Callea F, Dionisi-Vici C (2010) Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome. Pediatrics 126(1):e235\u2013e238. doi: 10.1542\/peds.2009-1639; 10.1542\/peds.2009-1639","journal-title":"Pediatrics"},{"issue":"5","key":"9_CR26","first-page":"311","volume":"19","author":"K Paradis","year":"1996","unstructured":"Paradis K (1996) Tyrosinemia: the quebec experience. Clinical and investigative medicine. Med Clin Exp 19(5):311\u2013316","journal-title":"Med Clin Exp"},{"issue":"Suppl 1","key":"9_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000111717","volume":"72","author":"SB Paul","year":"2007","unstructured":"Paul SB, Gulati MS, Sreenivas V, Madan K, Gupta AK, Mukhopadhyay S, Acharya SK (2007) Evaluating patients with cirrhosis for hepatocellular carcinoma: Value of clinical symptomatology, imaging and alpha-fetoprotein. Oncology 72(Suppl 1):117\u2013123","journal-title":"Oncology"},{"issue":"3","key":"9_CR28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","volume":"4","author":"PA Russo","year":"2001","unstructured":"Russo PA, Mitchell GA, Tanguay RM (2001) Tyrosinemia: a review. Pediatr Dev Pathol: Off J Soc Pediatr Pathol Paediat Pathol Soc 4(3):212\u2013221","journal-title":"Pediatr Dev Pathol: Off J Soc Pediatr Pathol Paediat Pathol Soc"},{"issue":"2","key":"9_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1478-3231.2007.01655.x","volume":"28","author":"B Saar","year":"2008","unstructured":"Saar B, Kellner-Weldon F (2008) Radiological diagnosis of hepatocellular carcinoma. Liver Int: Off J Int Assoc Study Liver 28(2):189\u2013199. doi: 10.1111\/j.1478-3231.2007.01655.x","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"issue":"5","key":"9_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1651-2227.1992.tb12270.x","volume":"81","author":"A Salt","year":"1992","unstructured":"Salt A, Barnes ND, Rolles K, Calne RY, Clayton PT, Leonard JV (1992) Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation. Acta Paediatr (Oslo, Norway : 1992) 81(5):449\u2013452","journal-title":"Acta Paediatr (Oslo, Norway : 1992)"},{"issue":"4","key":"9_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3978\/j.issn.2224-4336.2015.10.08","volume":"4","author":"DA Schady","year":"2015","unstructured":"Schady DA, Roy A, Finegold MJ (2015) Liver tumors in children with metabolic disorders. Transl Pediatr 4(4):290\u2013303. doi: 10.3978\/j.issn.2224-4336.2015.10.08","journal-title":"Transl Pediatr"},{"issue":"3","key":"9_CR32","doi-asserted-by":"publisher","first-page":"e749","DOI":"10.1542\/peds.2014-1913","volume":"135","author":"WG Ginkel van","year":"2015","unstructured":"van Ginkel WG, Gouw AS, van der Jagt EJ, de Jong KP, Verkade HJ, van Spronsen FJ (2015) Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP. Pediatrics 135(3):e749\u2013e752. doi: 10.1542\/peds.2014-1913","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"9_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF03335416","volume":"12","author":"FJ Spronsen van","year":"1989","unstructured":"van Spronsen FJ, Berger R, Smit GP, de Klerk JB, Duran M, Bijleveld CM et al (1989) Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem. J Inherit Metab Dis 12(Suppl 2):339\u2013342","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005176-200501000-00017","volume":"40","author":"FJ Spronsen van","year":"2005","unstructured":"van Spronsen FJ, Bijleveld CM, van Maldegem BT, Wijburg FA (2005) Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment. J Pediatr Gastroenterol Nutr 40(1):90\u201393","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"9_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00711742","volume":"18","author":"FJ Spronsen van","year":"1995","unstructured":"van Spronsen FJ, Smit GP, Wijburg FA, Thomasse Y, Visser G, Heymans HS (1995) Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation. J Inherit Metab Dis 18(2):111\u2013114","journal-title":"J Inherit Metab Dis"},{"key":"9_CR36","doi-asserted-by":"crossref","unstructured":"van Spronsen FJ, Thomasse Y, Smit GP, Leonard JV, Clayton PT, Fidler V, \u2026 Heymans HS (1994) Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology (Baltimore, Md.) 20(5):1187\u20131191. doi:S027091399400340X [pii]","DOI":"10.1002\/hep.1840200513"},{"issue":"3","key":"9_CR37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0022-3476(76)80259-4","volume":"88","author":"AG Weinberg","year":"1976","unstructured":"Weinberg AG, Mize CE, Worthen HG (1976) The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr 88(3):434\u2013438","journal-title":"J Pediatr"},{"issue":"4","key":"9_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5223\/pghn.2013.16.4.207","volume":"16","author":"NA Yazigi","year":"2013","unstructured":"Yazigi NA (2013) Long term outcomes after pediatric liver transplantation. Pediatr Gastroenterol Hepatol Nutr 16(4):207\u2013218. doi: 10.5223\/pghn.2013.16.4.207","journal-title":"Pediatr Gastroenterol Hepatol Nutr"}],"container-title":["Advances in Experimental Medicine and Biology","Hereditary Tyrosinemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-55780-9_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:07:09Z","timestamp":1719349629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-55780-9_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319557793","9783319557809"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-55780-9_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}